Navigation Links
AIDS Generic Drugs Approved by FDA for Sale in US

Expiry of Patent period for branded Zidovudine in US has lead to approval of FDA for new generic version of AZT, which would cost less and can be imported from other countries.

Zidovudine (AZT), is an anti-retroviral drug used in the // treatment of AIDS, the drug prevents the replication of the virus inside the humans by stopping the multiplication of the virus. The drug is also used in combination with other anti-retroviral drugs to combat HIV infection. Generic drugs of Zidovudine was not available in US market due to strict patent laws, so the people can use only branded Zidovudine drugs, as branded drugs are very costly, treatment using AZT has been very costly in the US. Due to expiry of the patents in the US for Zidovudine, now generic drugs can be sold and brought in US, though generic drugs are cheaper compared to branded drugs, some critics and pharmaceutical giants worry about the quality and safety of using the generic drugs. Now that those patents have expired, versions of drug manufactured by Roxane Laboratories of Columbus, Ohio; Ranbaxy Laboratories of Gurgaon, India, and Aurobindo Pharma of Hyderabad, India, can go on the market. The drug Retrovir which was approved in 1987, manufactured by GlaxoSmithKline and approved by FDA costs about $7 for one 300 milligram tablet.

“These approvals will now allow those infected with HIV more access to these life-saving drugs within our country,” said Mike Leavitt, secretary of the Department of Health and Human Services, in a statement.

(Source: The Associated Press)
'"/>




Page: 1

Related medicine news :

1. Generic drug costs remain shackled
2. FDA Approves Indian Generic Drug For AIDS Treatment
3. Proper Validation of Generic Drugs Could Save Millions of AIDS Patients
4. HIV Mortality declining in India due to Generic Antiretroviral therapy drugs
5. Generic Drugs Usage In US Can Save $20 Billion – Express Script Surve
6. Generic Products Compete With GlaxoSmithKline
7. ViroPharma Shares Fall As FDA Moves Towards Generic Vancocin
8. Ranbaxy Expands By Acquiring A Generic Company In Belgium
9. First Generic Version of Lexapro permitted by US
10. Dr Reddys Launches Generic Version Of Mercks Proscar Tablets
11. Ranbaxy Acquires Glaxosmithklines Generic Unit in Spain
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/25/2017)... ... 25, 2017 , ... The doctors at Wall Centre Dental are now expanding ... and require sedation to receive dental care. The doctors offer three treatment options to ... cleanings to oral surgery, at their dental office in Vancouver. Wall Centre Dental is ...
(Date:4/25/2017)... ... April 25, 2017 , ... Patients ... that achieves results in a fraction of the time as traditional braces – ... Significance Dental Specialists, now offers this revolutionary treatment with or without a referral. ...
(Date:4/25/2017)... ... April 25, 2017 , ... As Spring reignites vigilance ... research related to Zika virus during pregnancy, as well as other prenatal exposures ... science. , The Teratology Society is an international and multidisciplinary ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... Buyers and ... recreational users to dispensaries and head shops –can’t help but be heartened by the ... the tell-tale cannabis odor aptly described as “skunk smell.” At last they can ...
(Date:4/25/2017)... Clara, CA (PRWEB) , ... April 25, 2017 ... ... announces the addition of predictive analytics to its patient care management module. Using ... compliance even before a patient has been initiated on continuous positive airway pressure ...
Breaking Medicine News(10 mins):
(Date:4/18/2017)... , April 18, 2017  Cardinal Health (NYSE: ... 1 fiscal 2017 earnings per share (EPS) guidance ... 2019.  This is in conjunction with this morning,s announcement ... Vein Thrombosis and Nutritional Insufficiency businesses. Cardinal ... continuing operations will be at the bottom of its ...
(Date:4/18/2017)... , April 18, 2017 Viverae ® , ... announce the integration of IBM ® Watson Campaign ... deliver targeted communications for a personalized experience. Through digital ... on their health in real time. The enhanced experience ... most to members, wherever they are in their journey ...
(Date:4/18/2017)... -- Astute Medical, Inc., developer of biomarkers for better healthcare, ... the 2017 National Kidney Foundation (NKF) Spring Clinical ... 22. Physicians will present data on two biomarkers, ... acute kidney injury (AKI) during the management of patients ... Elevated levels of TIMP-2 and IGFBP-7 have been shown ...
Breaking Medicine Technology: